|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Diabetic nephropathy:Is it time yet for routine kidney biopsy?显示文摘Diabetic nephropathy(DN)is one of the most important long-term complications of diabetes.Patients with diabetes and chronic kidney disease have an increased risk of all-cause mortality,cardiovascular mortality,and kidney failure.The clinical diagnosis of DN depends on the detection of microalbuminuria.This usually occurs after the first five years from the onset of diabetes,and predictors of DN development and progression are being studied but are not yet implemented into clinical practice.Diagnostic tests are useful tools to recognize onset,progression and response to therapeutic interventions.Microalbuminuria is an indicator of DN,and it is considered the only noninvasive marker of early onset.However,up to now there is no diagnostic tool that can predict which patients will develop DN before any damage is present.Pathological renal injury is hard to predict only with clinical and laboratory findings.An accurate estimate of damage in DN can only be achieved by the histological analysis of tissue samples.At the present time,renal biopsy is indicated on patients with diabetes under the suspicion of the presence of nephropathies other than DN.Results from renal biopsies in patients with diabetes had made possible the classification of renal biopsies in three major groups associated with different prognostic features:diabetic nephropathy,non-diabetic renal disease(NDRD),and a superimposed non-diabetic condition on underlying diabetic nephropathy.In patients with type 2 diabetes with a higher degree of suspicion for NDRD,it is granted the need of a renal biopsy.It is important to identify and differentiate these pathologies at an early stage in order to prevent progression and potential complications.Therefore,a more extensive use of biopsy is advisable. | Maria L Gonzalez Suarez David B Thomas Laura Barisoni Alessia Fornoni | 2013 | World Journal of Diabetes2013，4，6： | 29 |
| 2 | Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)显示文摘 | Inzucchi Silvio E Bergenstal Richard M Buse John B Diamant Michaela Ferrannini Ele Nauck Michael Peters Anne L Tsapas Apostolos Wender Richard Matthews David R | 2012 | EN2012，，3： | 6 |
| 3 | MicroRNA-let-7a promotes E2F-mediated cell proliferation and NFKB activation in vitro显示文摘Epigenetic 因素,包括的改变的 microRNA (miRNA ) 表示,可以在全身的豺狼座 erythematosus (SLE ) 贡献异常有免疫力的房间功能。MiRNA-let-7a (let-7a ) 被显示了直接改变房间周期前进和 proinflammatory cytokine 生产。由于在房间分割和发炎的 let-7a 的关键角色,我们调查了 let-7a-mediated 增长和 NFκ在 J774A.1 巨噬细胞和 MES 的 B translocation 在 vitro 的 13 个 mesangial 房间。在有 let-7a 的刺激免疫者的房间 transfected,房间增长显著地随着时间的过去被增加。在 S 和 G 2 阶段的刺激免疫者的房间的数字有重要增加。刺激免疫者的房间 overexpressing let-7a 增加了 NFκ 的原子 translocation; B。Bioinformatical 分析表明 E2F 家庭, G 1-S 转变的批评管理者,在他们的 mRNA 抄本为 let-7a 有潜在的有约束力的地点。Let-7a overexpression 显著地增加了房间周期使活跃之物 E2F2 的表示并且在刺激免疫者的房间增加了 retinoblastoma 蛋白质(Rb ) phosphorylation。房间周期禁止者 E2F5 显著地在刺激免疫者的 let-7a-transfected 房间被减少。Bioinformatical 分析揭示了 E2F2 和 NFκ B 是预言调整 let-7a 倡导者的抄写因素。我们与 E2F2 和 NFκ 用染色质 immunoprecipitation 由即时 RT-PCR 分析了 let-7a 的 transcriptional 规定; B 抗体。E2F2 和 NFκ 有增加;在在刺激免疫者的房间为 let-7a 倡导者充实的 DNA 的 B 绑定。Silencing E2F2 或 NFκ B 显著地减少了在刺激免疫者的房间的 let-7a 表示和 IL-6 生产。一起拿,我们的结果建议 let-7a 的 overexpression 可以在 SLE 贡献增生和 proinflammatory 反应。 | Cristen B Chafin Nicole L Regna David L Caudell Christopher M Reilly | 2014 | Cellular & Molecular Immunology2014，11，1： | 3 |
| 4 | Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial显示文摘 | David N Krag Stewart J Anderson Thomas B Julian Ann M Brown Seth P Harlow Joseph P Costantino Takamaru Ashikaga Donald L Weaver Eleftherios P Mamounas Lynne M Jalovec Thomas G Frazier R Dirk Noyes André Robidoux Hugh MC Scarth Norman Wolmark | 2010 | Lancet Oncology2010，，10： | 3 |
| 5 | Heat shock protein 90 inhibition by 17-DMAG lessens disease in the MRL/Ipr mouse model of systemic lupus erythematosus显示文摘热吃惊蛋白质 90 的提高的表示(HSP90 ) 在全身的豺狼座 erythematosus (SLE ) 的肾和浆液被发现了病人和 MRL/Mp-Fas lpr /Fas lpr (MRL/lpr ) 自体免疫的老鼠。如果 HSP90 的抑制将在 MRL/lpr 老鼠减少疾病,我们调查了。在在 vivo 的 vitro,有在 IL-6 的有免疫力刺激的显示出的减少的表示以前的 HSP90 禁止者 Geldanamycin 的 mesangial 房间的预告的处理, IL-12 和号码,我们发现当与 C57BL/6 相比鼠标和 MRL/lpr 鼠标与 HSP90 禁止者 17-DMAG 对待时, HSP90 表示在 MRL/lpr 肾被提高。与 17-DMAG 对待的 MRL/lpr 老鼠显示出减少的 proteinuria 并且减少了浆液 anti-dsDNA 抗体生产。Glomerulonephritis 和 glomerular IgG 和 C3 没被 17-DMAG 的管理显著地在 MRL/lpr 影响。17-DMAG 增加了 CD8 + T 房间,减少的双 negative T 房间,减少 CD4/CD8 比率和减少的小囊的 B 房间。这些研究建议 HSP90 可以在调整 T 房间区别和激活起一个作用并且 HSP90 抑制可以在豺狼座减少发炎。 | Samuel K Shimp III Cristen B Chafin Nicole L Regna Sarah E Hammond Molly A Read David L Caudell Marissa Nichole Rylander Christopher M Reilly | 2012 | Cellular & Molecular Immunology2012，9，3： | 3 |
| 6 | DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice显示文摘 | Meira Lisiane B Bugni James M Green Stephanie L Lee Chung-Wei Pang Bo Borenshtein Diana Rickman Barry H Rogers Arlin B Moroski-Erkul Catherine A McFaline Jose L Schauer David B Dedon Peter C Fox James G Samson Leona D | 2008 | Journal of Clinical Investigation2008，，7： | 2 |
| 7 | DNA vaccination of infants in the presence of maternal antibody: a measles model in the primate显示文摘 | Mary Premenko-Lanier Paul A Rota Gary Rhodes David Verhoeven Dan H Barouch Nicholas W Lerche Norman L Letvin William J Bellini Michael B McChesney | 2003 | Virology2003，，1： | 2 |
| 8 | Endoscopic ultrasound-guided fiducial marker placement in pancreatic cancer:A systematic review and meta-analysis显示文摘BACKGROUND Pancreatic cancer(PC)mortality remains high despite advances in therapy.Combination chemoradiotherapy offers modest survival benefit over monotherapy with either.Fiducial markers serve as needed landmarks for imageguided radiotherapy(IGRT).Traditionally,these markers were placed surgically or percutaneously with limitations of each.Endoscopic ultrasound-guided placement overcomes these limitations.AIM To evaluate the safety,efficacy,and feasibility of endoscopic ultrasound(EUS)-guided fiducial placement for PC undergoing IGRT.METHODS Articles were searched in MEDLINE,PubMed,and Ovid journals.Pooling was conducted by fixed and random effects models.Heterogeneity was assessed using Cochran’s Q test based upon inverse variance weights.RESULTS Initial search identified 1024 reference articles for EUS-guided fiducial placement in PC.Of these,261 relevant articles were reviewed.Data was extracted from 11 studies(n=820)meeting inclusion criteria.Pooled proportion of successful placement was 96.27%(95%CI:95.35-97.81)with fiducial migration rates low at 4.33%(95%CI:2.45-6.71).Adverse event rates remained low,with overall pooled proportion of 4.85%(95%CI:3.04-7.03).CONCLUSION EUS-guided placement of fiducial markers for IGRT of PC is safe,feasible,and efficacious.The ability to target deep structures under direct visualization while remaining minimally invasive are added benefits.Moreover,the ability to perform fine needle aspiration or celiac plexus neurolysis add value and increase patient-care efficiency.Whether EUS-guided fiducial placement improves outcomes in IGRT or offers any mortality benefits over traditional placement remains unknown and future studies are needed. | Jaymon B Patel Vakya Revanur David G Forcione Matthew L Bechtold Srinivas R Puli | 2020 | World Journal of Gastrointestinal Endoscopy2020，12，8： | 2 |
| 9 | Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial显示文摘 | David N Krag Stewart J Anderson Thomas B Julian Ann M Brown Seth P Harlow Takamaru Ashikaga Donald L Weaver Barbara J Miller Lynne M Jalovec Thomas G Frazier R Dirk Noyes André Robidoux Hugh MC Scarth Denise M Mammolito David R McCready Eleftherios P Mamo | 2007 | Lancet Oncology2007，，10： | 2 |
| 10 | A method for the solubilization of a (1→3)-β-D-glucan isolated from Saccharomyces cerevisiae显示文摘 | Williams David L McNamee Rose B Jones Ernest L | 1991 | Carbohydrate Research1991，219，： | 1 |
| 11 | Synthesis and evaluation of advanced nanocrystalline tungsten-based materials显示文摘 | David L B | 1999 | P/M Science and Technology Brief1999，1，1： | 1 |
| 12 | Variable estimates of cytokine levels produced by commerical ELISA kits:results using international cytokine standards显示文摘 | Ledur A Fitting L David B | 2005 | Immunol Methods2005，186，： | 1 |
| 13 | Effect of spray characteristics on insecticide efficacy 显示文摘 | Randall G L David B S | 1990 | Pestic Formul Applic Syst1990，10，： | 1 |
| 14 | Creativity and Learning in a Case-based Explainer显示文摘 | Roger C S David B L | 1989 | AI1989，40，13： | 1 |
| 15 | Evidence for a causal role of low energy availability in the induction of menstrual cycle disturbances during strenuous exercise training显示文摘 | Nancy I Williams Dana L Helmreich David B Parfitt | 2001 | J Clin Endocrinol Metab2001，86，： | 1 |
| 16 | Intercalated organic-inorganic perovskites stabilized by flouroaryl-aryl interactions 显示文摘 | David B Mitzi David R Medeiros Patrick R L Malentant | 2002 | Inorg Chem2002，41，： | 1 |
| 17 | Regulation of epidermal apoptosis and DNA repair by E2F1 in response to ultraviolet B radiation显示文摘 | THOMAS R B DAVID L M GUO R F | 2005 | Oncogene2005，24，15： | 1 |
| 18 | A Method for Quantifying Vulnerability, Applied to the Agricultural System of the YaquiValley, Mexico 显示文摘 | Amy LL David B L Leonard S S | 2003 | Global Environmental Change2003，13，： | 1 |
| 19 | Estimation of tropical forest structural characteristics using large-footprint lidar显示文摘 | Jason B Drake Ralph O Dubayah David B Clark Robert G Knox J.Bryan Blair Michelle A Hofton Robin L Chazdon John F Weishampel Steve Prince | 2001 | Remote Sensing of Environment2001，，2： | 1 |
| 20 | Metropolitan areas and the measurement of American urbanization显示文摘 | David L B John B C | 2004 | Population Research and Policy Review2004，23，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员